NCT00321321View on ClinicalTrials.gov

The Beta Cell Responsiveness to Glucose-dependent Insulinotropic Polypeptide (GIP) With and Without Sulfonylurea in Patients With Type 2 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

March 31, 2007

Study Completion Date

April 30, 2007

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Sulfonylurea

Trial Locations (1)

2900

Department of Internal Medicine, Gentofte University Hospital, Hellerup, Copenhagen

All Listed Sponsors
lead

University Hospital, Gentofte, Copenhagen

OTHER

NCT00321321 - The Beta Cell Responsiveness to Glucose-dependent Insulinotropic Polypeptide (GIP) With and Without Sulfonylurea in Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter